Back to Search Start Over

Abstract 1686: Comprehensive genomic and transcriptomic profiling of gastrointestinal stromal tumors

Authors :
Peter Horak
Matea Hajnic
Laura Gieldon
Mario Hlevnjak
Susan Richter
Barbara Hutter
Johanna Falkenhorst
Sebastian Uhrig
Gregor Warsow
Nagarajan Paramasivam
Stefan Gröschel
Barbara Klink
Simon Kreutzfeldt
Christoph Heining
Christoph E. Heilig
Martina Fröhlich
Stephan Richter
Christian Brandts
Wilko Weichert
Philipp Jost
Olaf Neumann
Marc Zapatka
Albrecht Stenzinger
Alexander Marx
Benedikt Brors
Evelin Schröck
Sebastian Bauer
Peter Hohenberger
Hanno Glimm
Claudia Scholl
Stefan Fröhling
Source :
Cancer Research. 79:1686-1686
Publication Year :
2019
Publisher :
American Association for Cancer Research (AACR), 2019.

Abstract

Most adult gastrointestinal stromal tumors (GIST) are driven by activating KIT or PDGFRA mutations. The remaining 10-15% of cases, often referred to as wildtype (WT) GIST, display either alterations of the succinate dehydrogenase complex (SDH) or RAS pathway mutations. To gain additional insight into the biology of GIST, we performed whole-exome or genome and RNA sequencing in 38 GIST patients (WT, n=15; KIT-mutant, n=21; PDGFRA-mutant, n=2) enrolled in a prospective molecular stratification trial of NCT Heidelberg/Dresden and the German Cancer Consortium (DKTK) designed for younger adults with advanced-stage cancer across histologies and patients with rare tumors (NCT/DKTK MASTER). Of the 15 patients with WT GIST, 3 had pathogenic germline mutations in NF1 and 9 harbored SDH alterations (germline, n=5; somatic, n=4). In the 3 patients with quadruple-negative GIST - defined by the absence of KIT, PDGFRA, SDH, or RAS pathway alterations - we detected novel gene fusions affecting RET, FGFR2, and FGF4, respectively. To delineate biologically relevant subgroups of GIST based on RNA sequencing data from the entire cohort (n=34), we used 3 different clustering methods and 4 different measures of stability and consistency. Despite the underlying clinical and molecular heterogeneity, we identified 3 distinct transcriptional subgroups that were characterized by (i) SDH deficiency, (ii) recurrent somatic RB1 alterations and mutational signatures associated with defective homologous recombination DNA repair, and (iii) elevated PDGFRA expression, respectively. Furthermore, we used random forest analysis to identifiy genes that are significantly (p Citation Format: Peter Horak, Matea Hajnic, Laura Gieldon, Mario Hlevnjak, Susan Richter, Barbara Hutter, Johanna Falkenhorst, Sebastian Uhrig, Gregor Warsow, Nagarajan Paramasivam, Stefan Gröschel, Barbara Klink, Simon Kreutzfeldt, Christoph Heining, Christoph E. Heilig, Martina Fröhlich, Stephan Richter, Christian Brandts, Wilko Weichert, Philipp Jost, Olaf Neumann, Marc Zapatka, Albrecht Stenzinger, Alexander Marx, Benedikt Brors, Evelin Schröck, Sebastian Bauer, Peter Hohenberger, Hanno Glimm, Claudia Scholl, Stefan Fröhling. Comprehensive genomic and transcriptomic profiling of gastrointestinal stromal tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1686.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
15387445 and 00085472
Volume :
79
Database :
OpenAIRE
Journal :
Cancer Research
Accession number :
edsair.doi...........d1e584d2603a9c17829776279852a197